Angel Silveyra v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2023)

Angel Silveyra filed a petition for compensation under the National Vaccine Injury Compensation Program on September 16, 2020, alleging that he suffered injuries, including Guillain-Barre Syndrome (GBS), as a result of an influenza vaccine received on October 8, 2018. Mr.

Silveyra stated that the vaccine was administered in the United States, that he experienced residual effects of the injury for more than six months, and that there had been no prior award or settlement for his condition. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused petitioner's GBS or any other injury.

Despite this denial, the parties filed a joint stipulation for compensation on January 27, 2023. Chief Special Master Brian H.

Corcoran reviewed the stipulation, found it reasonable, and adopted it as his decision. The decision awarded Angel Silveyra a lump sum of $175,000.00, payable by check to the Petitioner, as compensation for all items of damages.

The public decision does not describe the specific onset of symptoms, clinical details of the GBS, diagnostic tests performed, or treatments received. Petitioner's counsel was Nancy Routh Meyers of Turning Point Litigation, and respondent's counsel was Amanda Pasciuto of the U.S.

Department of Justice. The decision was issued on January 27, 2023.